Related Experiment Video
Updated: Jul 8, 2026
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Prompt, aggressive BP lowering in high-risk patients
Kenneth A Jamerson1, Jan Basile
1Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan Health Care System, Ann Arbor, MI 48109, USA. jamerson@umich.edu
Insights
Aggressively treating hypertension in high-risk patients, including those with stage 2 hypertension, diabetes, or heart disease, is crucial. Early combination therapy, such as with calcium channel blockers and renin-angiotensin system inhibitors, improves outcomes.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Current guidelines identify specific high-risk populations for hypertension requiring tailored treatment.
- These groups, including patients with stage 2 hypertension, Black individuals, and those with diabetes or coronary heart disease, face elevated cardiovascular risks.
Purpose of the Study:
- To review current knowledge on hypertension management in high-risk populations.
- To emphasize the importance of prompt, aggressive blood pressure lowering to prevent cardiovascular disease progression.
Main Methods:
- Review of current medical literature and treatment guidelines.
- Focus on evidence-based antihypertensive strategies for specific patient groups.
Main Results:
- Hypertension in high-risk groups is linked to increased cardiovascular morbidity and mortality.
- Early initiation of multiple-drug therapy with complementary mechanisms is recommended.
- Calcium channel blockers combined with renin-angiotensin system inhibitors show promise for improved outcomes.
Conclusions:
- Prompt and aggressive blood pressure control is vital for high-risk hypertensive patients.
- Combination antihypertensive therapy, potentially including calcium channel blockers and renin-angiotensin system inhibitors, is an effective strategy.
- Tailored treatment approaches are essential to mitigate cardiovascular risks in diverse hypertensive populations.
Abstract:
Various populations with hypertension have been singled out by current treatment guidelines as requiring more specific treatment. These include patients with stage 2 hypertension, black patients, and patients with coexistent diabetes mellitus and coronary heart disease. Hypertension in these groups is often associated with higher risk of cardiovascular morbidity and mortality. This article reviews current knowledge regarding hypertension in high-risk patient populations, with a particular focus on the importance of prompt, aggressive treatment to lower blood pressure and prevent cardiovascular disease progression. Such treatment includes the early use of multiple-drug therapy with agents that have complementary blood pressure-lowering mechanisms and provide protection from target organ damage. While 2- or 3-drug antihypertensive therapy in these high-risk groups has typically included a diuretic, other combinations of agents may be indicated. Evidence suggests that therapy with a calcium channel blocker and an inhibitor of the renin-angiotensin system is one effective strategy for lowering blood pressure and improving outcomes in these populations.
Related Concept Videos
01:28Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
01:15Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:
01:23Hypertension V: Nursing Management
01:17Measurement of Blood Pressure
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System